Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Faillie, JL"'
Publikováno v:
In Journal of Stomatology oral and Maxillofacial Surgery October 2022 123(5):e448-e453
Autor:
Faillie, JL, Ferrer, P, Gouverneur, A, Driot, D, Berkemeyer, S, Vidal, X, Martinez-Zapata, MJ, Huerta, C, Castells, X, Rottenkolber, M, Schmiedl, S, Sabate, M, Ballarin, E, Ibanez, L
Publikováno v:
JOURNAL OF CLINICAL EPIDEMIOLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Objectives: The objective of the study was to develop and validate an adequate tool to evaluate the risk of bias of randomized controlled trials, observational studies, and systematic reviews assessing drug adverse events. Study Design and Setting: W
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::819d3312f4d43f135f221ccfd8af8413
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6404
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=6404
Publikováno v:
Lancet. 10/29/2011, Vol. 378 Issue 9802, p1543-1545. 4p.
Autor:
Mehalaine, Adel, Polge, Anne, Faillie, Jl, Thuillier, Mickael, Soullier, Camille, Brouillet, Jean Paul, Lumbroso, Serge, Bertinchant, Jean Pierre
Publikováno v:
In Archives of Cardiovascular Diseases Supplements January 2012 4(1):25-25
Autor:
Pariente A; Univ Bordeaux, INSERM, BPH, U1219, Team AHeaD, 33000, Bordeaux, France. antoine.pariente@u-bordeaux.fr.; CHU de Bordeaux, Service de Pharmacologie Médicale, Unité Pharmacoépidémiologie et Bon Usage du Médicament, 33000, Bordeaux, France. antoine.pariente@u-bordeaux.fr., Salvo F; Univ Bordeaux, INSERM, BPH, U1219, Team AHeaD, 33000, Bordeaux, France.; CHU de Bordeaux, Service de Pharmacologie Médicale-Centre Régional de Pharmacovigilance, 33000, Bordeaux, France., Bres V; CHU Montpellier, Service de Pharmacologie Médicale et Toxicologie-Centre Régional de Pharmacovigilance, 34090, Montpellier, France., Faillie JL; CHU Montpellier, Service de Pharmacologie Médicale et Toxicologie-Centre Régional de Pharmacovigilance, 34090, Montpellier, France.; Universitaire Montpellier, INSERM, Institut Desbrest d'Épidémiologie et de Santé Publique, 34090, Montpellier, France.
Publikováno v:
Drug safety [Drug Saf] 2024 Sep; Vol. 47 (9), pp. 921-923. Date of Electronic Publication: 2024 May 08.
Autor:
Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, Bordeaux, France., Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Université de Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France.
Publikováno v:
JAMA network open [JAMA Netw Open] 2024 Aug 01; Vol. 7 (8), pp. e2423335. Date of Electronic Publication: 2024 Aug 01.
Autor:
Meunier L; Department of Hepatogastroenterology and Liver Transplantation, Universitary Hospital Centre Montpellier, University of Montpellier, Montpellier, France; Institute for Regenerative Medicine and Biotherapy, University of Montpellier, Montpellier, France., Hountondji L; Department of Hepatogastroenterology and Liver Transplantation, Universitary Hospital Centre Montpellier, University of Montpellier, Montpellier, France., Jantzem H; Department of Pharmacovigilance, Universitary Hospital Centre Brest, Brest, France., Faillie JL; Department of Medical Pharmacology and Toxicology, Universitary Hospital Centre Montpellier, University of Montpellier, Montpellier, France; Desbrest Institute of Epidemiology and Public Health, INSERM, University of Montpellier, Montpellier, France., Maria A; Internal Medicine and Immuno-Oncology, Institute for Regenerative Medicine and Biotherapy, Universitary Hospital Centre Montpellier, University of Montpellier, Montpellier, France., Palassin P; Department of Medical Pharmacology and Toxicology, Universitary Hospital Centre Montpellier, University of Montpellier, Montpellier, France.
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association [Clin Gastroenterol Hepatol] 2024 Jul; Vol. 22 (7), pp. 1542-1545.e4. Date of Electronic Publication: 2023 Dec 16.
Autor:
Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. michele.fusaroli2@unibo.it., Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France. francesco.salvo@u-bordeaux.fr., Begaud B; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France., AlShammari TM; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia., Bate A; Global Safety, GSK, Brentford, UK.; Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK., Battini V; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Brueckner A; Novartis Pharma AG, Basel, Switzerland., Candore G; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany., Carnovale C; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Crisafulli S; Department of Medicine, University of Verona, Verona, Italy., Cutroneo PM; Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre, University Hospital of Messina, Messina, Italy., Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France., Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center, Nice, France., Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Univ Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France., Goldman A; Department of Internal Medicine, Sheba Medical Center, Ramat-Gan, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Hauben M; Pfizer Inc, New York, NY, USA.; Department of Family and Community Medicine, New York Medical College, Valhalla, New York, USA., Herdeiro MT; Department of Medical Sciences, IBIMED-Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal., Mahaux O; Global Safety, GSK, Brentford, UK., Manlik K; Medical Affairs and Pharmacovigilance, Bayer AG, Berlin, Germany., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, Toulouse, France., Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan., Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden., Noseda R; Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, Switzerland., Onakpoya IJ; Department for Continuing Education, University of Oxford, Oxford, UK., Pariente A; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France., Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Salem M; Health Canada, Ottawa, ON, Canada., Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.; Centre for Evidence-Based Medicine, Nuffield, Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway., Tuccori M; Tuscany Regional Centre, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Pisa, Italy., van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands., van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, The Netherlands.; PharmacoTherapy, Epidemiology and Economics, University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands., Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Khouri C; Pharmacovigilance Department, Université Grenoble Alpes, Grenoble Alpes University Hospital, Grenoble, France.; UMR 1300-HP2 Laboratory, Université Grenoble Alpes, INSERM, Grenoble Alpes University, Grenoble, France.
Publikováno v:
Drug safety [Drug Saf] 2024 Jun; Vol. 47 (6), pp. 585-599. Date of Electronic Publication: 2024 May 07.
Autor:
Fusaroli M; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Salvo F; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France., Begaud B; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France., AlShammari TM; College of Pharmacy, Almaarefa University, Riyadh, Saudi Arabia., Bate A; Global Safety, GSK, Brentford, UK.; Department of Non-Communicable Epidemiology, London School of Hygiene and Tropical Medicine, London, UK., Battini V; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Brueckner A; Novartis, Basel, Switzerland., Candore G; Bayer AG, Medical Affairs and Pharmacovigilance, Berlin, Germany., Carnovale C; Pharmacovigilance and Clinical Research, International Centre for Pesticides and Health Risk Prevention, Department of Biomedical and Clinical Sciences (DIBIC), ASST Fatebenefratelli-Sacco University Hospital, Università degli Studi di Milano, Milan, Italy., Crisafulli S; Department of Medicine, University of Verona, Verona, Italy., Cutroneo PM; Unit of Clinical Pharmacology, Sicily Pharmacovigilance Regional Centre, University Hospital of Messina, Messina, Italy., Dolladille C; UNICAEN, EA4650 SEILIRM, CHU de Caen Normandie, Normandie University, Caen, France.; Department of Pharmacology, CHU de Caen Normandie, Caen, France., Drici MD; Department of Clinical Pharmacology, Université Côte d'Azur Medical Center, Nice, France., Faillie JL; Desbrest Institute of Epidemiology and Public Health, Department of Medical Pharmacology and Toxicology, INSERM, Univ Montpellier, Regional Pharmacovigilance Centre, CHU Montpellier, Montpellier, France., Goldman A; Department of Internal Medicine, Sheba Medical Center, Ramat-Gan, Israel.; Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel., Hauben M; Pfizer Inc., New York, USA.; Department of Family and Community Medicine, New York Medical College, Valhalla, New York, USA., Herdeiro MT; Department of Medical Sciences, IBIMED-Institute of Biomedicine, University of Aveiro, 3810-193, Aveiro, Portugal., Mahaux O; Global Safety, GSK, Brentford, UK., Manlik K; Bayer AG, Medical Affairs and Pharmacovigilance, Berlin, Germany., Montastruc F; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Faculty of Medicine, Toulouse University Hospital (CHU), Toulouse, France.; CIC 1436, Team PEPSS (Pharmacologie En Population cohorteS et biobanqueS), Toulouse University Hospital, Toulouse, France., Noguchi Y; Laboratory of Clinical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan., Norén GN; Uppsala Monitoring Centre, Uppsala, Sweden., Noseda R; Institute of Pharmacological Sciences of Southern Switzerland, Division of Clinical Pharmacology and Toxicology, Ente Ospedaliero Cantonale, Lugano, Switzerland., Onakpoya IJ; Department for Continuing Education, University of Oxford, Oxford, UK., Pariente A; Université de Bordeaux, INSERM, BPH, Team AHeaD, U1219, 33000, Bordeaux, France.; Service de Pharmacologie Médicale, CHU de Bordeaux, INSERM, U1219, 33000, Bordeaux, France., Poluzzi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy., Salem M; Health Canada, Ottawa, Canada., Sartori D; Uppsala Monitoring Centre, Uppsala, Sweden.; Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK., Trinh NTH; PharmacoEpidemiology and Drug Safety Research Group, Department of Pharmacy, University of Oslo, Oslo, Norway., Tuccori M; Tuscany Regional Centre, Unit of Adverse Drug Reaction Monitoring, University Hospital of Pisa, Pisa, Italy., van Hunsel F; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, the Netherlands., van Puijenbroek E; Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands.; University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, Epidemiology and Economics, Groningen, the Netherlands., Raschi E; Department of Medical and Surgical Sciences, Alma Mater Studiorum, University of Bologna, Bologna, Italy. emanuel.raschi@unibo.it., Khouri C; Pharmacovigilance Department, Univ. Grenoble Alpes, Grenoble Alpes University Hospital, Grenoble, France. ckhouri@chu-grenoble.fr.; UMR 1300-HP2 Laboratory, Univ. Grenoble Alpes, INSERM, Grenoble Alpes University, Grenoble, France. ckhouri@chu-grenoble.fr.
Publikováno v:
Drug safety [Drug Saf] 2024 Jun; Vol. 47 (6), pp. 575-584. Date of Electronic Publication: 2024 May 07.
Autor:
de Germay S; Univ. Bordeaux, INSERM, BPH, U1219 Team AHeaD, Bordeaux, France.; Department of Medical Pharmacology, CHU de Bordeaux, Bordeaux, France., Pambrun E; Univ. Bordeaux, INSERM, BPH, U1219 Team AHeaD, Bordeaux, France., Pariente A; Univ. Bordeaux, INSERM, BPH, U1219 Team AHeaD, Bordeaux, France.; Department of Medical Pharmacology, CHU de Bordeaux, Bordeaux, France., Grenet G; Department of Medical Pharmacotoxicology, Hospices Civils de Lyon, Lyon, France., Bezin J; Univ. Bordeaux, INSERM, BPH, U1219 Team AHeaD, Bordeaux, France.; Department of Medical Pharmacology, CHU de Bordeaux, Bordeaux, France., Faillie JL; Department of Medical Pharmacology and Toxicology, CHU Montpellier; Univ Montpellier, IDESP INSERM, Montpellier, France.
Publikováno v:
Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 May; Vol. 26 (5), pp. 1678-1686. Date of Electronic Publication: 2024 Jan 30.